Evidence map›Paper›PMID 28638586›Full record

ArticleMiddle East journal of digestive diseases2017

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for

Fariborz Mansour-Ghanaei, Zahra Pedarpour, Afshin Shafaghi, Farahnaz Joukar

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Middle East journal of digestive diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Fourth-generation quinolones in the treatment ofWorld journal of gastroenterology · 2018
    Pooled it
  2. Article
  3. Article
  4. Eradication Treatment ofInfection and drug resistance · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Fariborz Mansour-GhanaeiProfessor, Gastrointestinal & Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Rasht, Iran.
Zahra PedarpourResearcher, GI Cancers Screening and Prevention Research Center (GCSPRC), Guilan University of Medical Sciences, Rasht, Iran.
Afshin ShafaghiAssociate Professor, GI Cancers Screening and Prevention Research Center (GCSPRC), Guilan University of Medical Sciences, Rasht, Iran.
Farahnaz JoukarPhD by Research student, Faculty member, Gastrointestinal & Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Rasht, Iran.
Guilan University of Medical Sciences · IRRazi Hospital · IRUniversity of Guilan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND

Indexed as

ClarithromycinEradication regimensGemifloxacinHelicobacter pylori infection

Identifiers

PMID28638586
PMCPMC5471100
OpenAlexW2609985457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.